iShares US Pharmaceuticals ETF
IHE
IHE
125 hedge funds and large institutions have $143M invested in iShares US Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 122 → 125 (+3)
Holders
125
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.35M | |
| 2 | +$5.23M | |
| 3 | +$4.08M | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$3.64M |
| 5 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$3.56M |
Top Sellers
| 1 | -$1.87M | |
| 2 | -$1.16M | |
| 3 | -$1.15M | |
| 4 |
SCA
Southern Capital Advisors
Jackson,
Tennessee
|
-$1.04M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$734K |